• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞和T细胞上CD83的表达:与有效免疫反应的相关性。

CD83 expression on dendritic cells and T cells: correlation with effective immune responses.

作者信息

Aerts-Toegaert Cindy, Heirman Carlo, Tuyaerts Sandra, Corthals Jurgen, Aerts Joeri L, Bonehill Aude, Thielemans Kris, Breckpot Karine

机构信息

Laboratory of Molecular and Cellular Therapy, Department of Physiology and Immunology, Medical School of the Vrije Universiteit Brussel, Brussels, Belgium.

出版信息

Eur J Immunol. 2007 Mar;37(3):686-95. doi: 10.1002/eji.200636535.

DOI:10.1002/eji.200636535
PMID:17301951
Abstract

Human CD83 is a marker molecule for mature dendritic cells (DC) and is also expressed on activated B and T cells. Although CD83 has been implicated in immune responses, its function on DC and T cells remains unclear. In this study, we wanted to assess the role of CD83 expressed on DC and T cells in the immune response. Down-regulation of CD83 expression on human DC through RNA interference (RNAi) results in a less potent induction of allogeneic T cell proliferation, reduced IFN-gamma secretion by established T cells and decreased capacity in the priming of functional tumor antigen-specific CD8+ T lymphocytes. In addition, CD83 mRNA-electroporated DC are stronger T cell stimulators. However, CD83 overexpression on Melan-A/MART-1-specific tumor-infiltrating lymphocytes (TIL) circumvents the need for CD83 expression on DC. Co-culture of immature DC with TIL or K562 cells overexpressing CD83 results in the production of enhanced levels of pro-inflammatory cytokines, whereas this production is less pronounced or even absent in co-cultures with non-modified TIL or K562 cells. In conclusion, we demonstrate that CD83 expression on T cells and DC modulates the immune response by activating DC and by delivering costimulatory signals for the stimulation of naive and memory T cells, respectively.

摘要

人CD83是成熟树突状细胞(DC)的标志物分子,在活化的B细胞和T细胞上也有表达。尽管CD83与免疫反应有关,但其在DC和T细胞上的功能仍不清楚。在本研究中,我们想评估DC和T细胞上表达的CD83在免疫反应中的作用。通过RNA干扰(RNAi)下调人DC上CD83的表达会导致异体T细胞增殖的诱导作用减弱,已建立的T细胞分泌的IFN-γ减少,以及功能性肿瘤抗原特异性CD8+ T淋巴细胞启动能力下降。此外,经CD83 mRNA电穿孔的DC是更强的T细胞刺激剂。然而,在黑色素瘤-A/MART-1特异性肿瘤浸润淋巴细胞(TIL)上过表达CD83可避免DC上对CD83表达的需求。未成熟DC与过表达CD83的TIL或K562细胞共培养会导致促炎细胞因子水平升高,而在与未修饰的TIL或K562细胞共培养时,这种产生不太明显甚至不存在。总之,我们证明T细胞和DC上的CD83表达分别通过激活DC和为刺激幼稚和记忆T细胞传递共刺激信号来调节免疫反应。

相似文献

1
CD83 expression on dendritic cells and T cells: correlation with effective immune responses.树突状细胞和T细胞上CD83的表达:与有效免疫反应的相关性。
Eur J Immunol. 2007 Mar;37(3):686-95. doi: 10.1002/eji.200636535.
2
[Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].卵巢癌细胞对人树突状细胞成熟及功能的影响
Zhonghua Yi Xue Za Zhi. 2009 Mar 10;89(9):630-4.
3
Enhanced T-cell activation and T-cell-dependent IL-2 production by CD83+, CD25high, CD43high human monocyte-derived dendritic cells.CD83+、CD25高、CD43高的人单核细胞衍生树突状细胞增强T细胞活化及T细胞依赖性白细胞介素-2的产生。
Mol Immunol. 2007 Mar;44(7):1544-50. doi: 10.1016/j.molimm.2006.08.020. Epub 2006 Oct 4.
4
CD2+/CD14+ monocytes rapidly differentiate into CD83+ dendritic cells.CD2+/CD14+单核细胞迅速分化为CD83+树突状细胞。
Eur J Immunol. 2003 Feb;33(2):358-67. doi: 10.1002/immu.200310010.
5
CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy.通过电穿孔用肿瘤肽cDNA转染的CD83 +人树突状细胞诱导特异性T细胞反应:一种基因免疫治疗的潜在工具。
Cancer Gene Ther. 2000 Apr;7(4):605-14. doi: 10.1038/sj.cgt.7700187.
6
Epicubenol and Ferruginol induce DC from human monocytes and differentiate IL-10-producing regulatory T cells in vitro.表没药烯醇和铁锈醇可从人单核细胞诱导产生树突状细胞,并在体外分化出产生白细胞介素-10的调节性T细胞。
Biochem Biophys Res Commun. 2005 Nov 18;337(2):730-8. doi: 10.1016/j.bbrc.2005.09.110. Epub 2005 Sep 26.
7
Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.小鼠骨髓间充质干细胞促使成熟树突状细胞促进T细胞耐受。
Scand J Immunol. 2008 Dec;68(6):607-15. doi: 10.1111/j.1365-3083.2008.02180.x. Epub 2008 Oct 27.
8
IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.白细胞介素-15诱导的人树突状细胞能有效地激活黑色素瘤特异性初始CD8⁺T细胞,使其分化为细胞毒性T淋巴细胞。
Eur J Immunol. 2007 Jun;37(6):1678-90. doi: 10.1002/eji.200636329.
9
alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.甲胎蛋白和白细胞介素-18基因修饰的树突状细胞在体外能有效刺激肝癌患者产生特异性1型CD4和CD8介导的T细胞应答。
Hum Immunol. 2007 May;68(5):334-41. doi: 10.1016/j.humimm.2007.01.008. Epub 2007 Feb 21.
10
Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell response.在干扰素-β和白细胞介素-3存在的情况下分化的树突状细胞是抗原特异性CD8 + T细胞反应的有效诱导剂。
J Leukoc Biol. 2005 Oct;78(4):898-908. doi: 10.1189/jlb.0105052. Epub 2005 Jul 21.

引用本文的文献

1
Research on inner membrane complex protein 1: a novel nanovaccines against Toxoplasma gondii.内膜复合蛋白1的研究:一种新型抗弓形虫纳米疫苗
BMC Vet Res. 2025 Aug 23;21(1):521. doi: 10.1186/s12917-025-04961-z.
2
An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purification.一种基于mRNA的工作流程,通过HLA-I/肽亲和纯化验证新表位呈递。
Front Immunol. 2025 Jun 4;16:1566461. doi: 10.3389/fimmu.2025.1566461. eCollection 2025.
3
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality.
简约转录组特征可实现对 COVID-19 死亡率的准确早期预测。
medRxiv. 2025 May 19:2025.05.18.25327658. doi: 10.1101/2025.05.18.25327658.
4
α2-3 Sialic Acids-Decorated Allergens Exert a Tolerogenic Effect on CD4+ T Cells from Der p 2-Allergic Patients.α2-3唾液酸修饰的变应原对来自Der p 2过敏患者的CD4+ T细胞具有致耐受性作用。
Int Arch Allergy Immunol. 2025;186(8):703-715. doi: 10.1159/000543157. Epub 2024 Dec 19.
5
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy.从实验室到临床的mRNA癌症疫苗:癌症免疫治疗的新时代。
Biomark Res. 2024 Dec 18;12(1):157. doi: 10.1186/s40364-024-00692-9.
6
The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells.不同FLT3抑制剂对树突状细胞的免疫调节作用。
Cancers (Basel). 2024 Nov 4;16(21):3719. doi: 10.3390/cancers16213719.
7
mRNA vaccines: a new era in vaccine development.mRNA 疫苗:疫苗开发的新时代。
Oncol Res. 2024 Sep 18;32(10):1543-1564. doi: 10.32604/or.2024.043987. eCollection 2024.
8
Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells.人工抗原呈递细胞:获得功能性过继细胞的助推器。
Cell Mol Life Sci. 2024 Aug 31;81(1):378. doi: 10.1007/s00018-024-05412-y.
9
Multiplex plasma protein assays as a diagnostic tool for lung cancer.多重血浆蛋白检测作为肺癌的一种诊断工具。
Cancer Sci. 2024 Oct;115(10):3439-3454. doi: 10.1111/cas.16300. Epub 2024 Jul 30.
10
Discovery of a novel ROS-based signature for predicting prognosis and immunosuppressive tumor microenvironment in lung adenocarcinoma.发现一种基于活性氧的新型标志物用于预测肺腺癌的预后和免疫抑制性肿瘤微环境。
J Cancer. 2024 Mar 17;15(9):2691-2711. doi: 10.7150/jca.93975. eCollection 2024.